2BBBullish & Bearish
KalVista Pharmaceuticals, Inc. (KALV) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 19 out of 100.
KalVista Pharmaceuticals, Inc.’s current 2BB score is 19 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 3 | Very Low |
| Momentum | 42 | Stable |
| Financial strength | 10 | Very Weak |
| Quality | 100 | Very Strong |
| Risk | 53 | Moderate |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2026-05-14 | -0.43 | -0.4828 | $40.86M | $39.58M |
| 2026-03-25 | 0.91684 | -0.4794 | — | — |
| 2026-03-25 | — | -0.0408 | — | $65.38M |
| 2026-03-17 | — | -0.51 | — | $29.27M |